Price To Earnings Ratio 22.54 | Sector PE 65.09 |
PB Ratio 3.28 | Sector PB 8.49 |
EPS 18.75 | Dividend Yield 0.00 |
Today's Volume 160.673 K | 5 Day Avg. Volume 150.424 K |
PEG Ratio 0.37 | Market Cap. ₹ 7,010.00 Cr. |
FDC Limited is an Indian company whose core business is the pharmaceutical industry. The company manufactures and distributes generic drugs, dosage forms and active ingredients in its own manufacturing facilities. It also manufactures oral rehydration salts (ORS) and specialty formulations. There is a selection of functional food and drinks. Its active pharmaceutical ingredients (API) include albuterol sulfate, bromhexine hydrochloride, cinnarizine, flunarizine dihydrochloride, flurbiprofen, flurbiprofen sodium, miconazole nitrate, and timolol maleate. It is found in various therapeutic segments such as anti-infective, gastrointestinal, ophthalmic, vitamins/minerals/dietary supplements, cardiac, diabetes, respiratory, gynecology, dermatology, analgesics and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.